We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

WERFEN

Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App





Werfen Offers In-Booth Instrument Demonstrations and Educational Workshop

By LabMedica International staff writers
Posted on 22 Jul 2023
Print article
Image: The ACL TOP Family 50 Series systems is a breakthrough in hemostasis testing (Photo courtesy of Werfen)
Image: The ACL TOP Family 50 Series systems is a breakthrough in hemostasis testing (Photo courtesy of Werfen)

Werfen (Barcelona, Spain) is offering in-booth demonstrations of its point-of-care and laboratory instruments, reagents, and data management solutions at AACC 2023. The company is also hosting an educational workshop focusing on the prevalence and impact of pre-analytical errors in point-of-care blood gas testing. Werfen is also hosting a press conference at the AACC to introduce and explain the company’s recent acquisition of Immucor, Inc. (Norcross, GA, USA).

Werfen provides a comprehensive and integrated range of products and services. From intensive care units to operating rooms, emergency departments to interventional radiology suites and cardiac catheterization labs, and central and satellite laboratories, the company’s testing solutions are designed to deliver quality results, quickly and simply, irrespective of the setting. At AACC 2023, Werfen is offering instrument demonstrations its wide range of systems, including the ACL TOP Family 50 Series, HemoCell Specialized Lab Automation, HemosIL assays, HemoHub Intelligent Data Manager; GEM Premier 5000, GEM Premier ChemSTAT, GEM Hemochron 100, ROTEM sigma, VerifyNow, GMweb Plus 500, Aptiva, BIO-FLASH, QUANTA-Lyser, QUANTA-Link; Echo Lumena, and NEO Iris. The company is also offering a virtual reality experience featuring customized layouts for HemoCell Lab Automation.

At AACC 2023, senior leaders from Werfen will introduce and explain the company’s recent acquisition of Immucor, an in vitro diagnostic company with strong global leadership in the clinical areas of transfusion and transplant. With the integration of Immucor, Werfen has expanded its presence in specialized diagnostics with seven technology centers and more than 7,000 employees worldwide. The company will continue to operate directly in 34 countries, and in more than 100 territories through distributors. Most importantly, Werfen can now offer its customers an even broader portfolio of products and solutions across hospital acute care settings, and contribute to the care of more patients around the world.

Related Links:
Werfen 
Immucor, Inc. 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test runs on the cobas liat system (Photo courtesy of Roche)

Four-In-One Molecular Test Detects and Differentiates Among Most Prevalent Respiratory Viruses in 20 Minutes

The U.S. Centers for Disease Control and Prevention (CDC) has reported that respiratory diseases in the United States reached high levels during the recent autumn and winter seasons, with SARS-CoV-2 leading... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.